Clinical Trials Browser

Phase 3 × fotemustine × Dermatologic × Clear all

NCT01359956 2023-04-11

SICOG 0109

Phase 3 Completed

269 enrolled 12 charts

Melanoma

NCT00110123 2012-09-24

Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

Phase 3 Terminated

Uveal Melanoma, Neoplasm Metastasis